Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:24159046  

Fine tuning of craniofacial morphology by distant-acting enhancers.

Catia Attanasio | Alex S Nord | Yiwen Zhu | Matthew J Blow | Zirong Li | Denise K Liberton | Harris Morrison | Ingrid Plajzer-Frick | Amy Holt | Roya Hosseini | Sengthavy Phouanenavong | Jennifer A Akiyama | Malak Shoukry | Veena Afzal | Edward M Rubin | David R FitzPatrick | Bing Ren | Benedikt Hallgrímsson | Len A Pennacchio | Axel Visel
Science (New York, N.Y.) | 2013

The shape of the human face and skull is largely genetically determined. However, the genomic basis of craniofacial morphology is incompletely understood and hypothesized to involve protein-coding genes, as well as gene regulatory sequences. We used a combination of epigenomic profiling, in vivo characterization of candidate enhancer sequences in transgenic mice, and targeted deletion experiments to examine the role of distant-acting enhancers in craniofacial development. We identified complex regulatory landscapes consisting of enhancers that drive spatially complex developmental expression patterns. Analysis of mouse lines in which individual craniofacial enhancers had been deleted revealed significant alterations of craniofacial shape, demonstrating the functional importance of enhancers in defining face and skull morphology. These results demonstrate that enhancers are involved in craniofacial development and suggest that enhancer sequence variation contributes to the diversity of human facial morphology.

Pubmed ID: 24159046

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NHGRI NIH HHS, United States
    Id: R01 HG003988
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U127561093
  • Agency: NIDCR NIH HHS, United States
    Id: R01 DE019638
  • Agency: NHGRI NIH HHS, United States
    Id: U54HG006997
  • Agency: NHGRI NIH HHS, United States
    Id: R01HG003991
  • Agency: NIDCR NIH HHS, United States
    Id: 1U01DE020054
  • Agency: NIGMS NIH HHS, United States
    Id: F32 GM105202
  • Agency: NIDCR NIH HHS, United States
    Id: U01DE020060
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_U127561093
  • Agency: NIDCR NIH HHS, United States
    Id: R01 DE021708
  • Agency: NIDCR NIH HHS, United States
    Id: 1R01DE021708
  • Agency: NIDCR NIH HHS, United States
    Id: U01 DE020060
  • Agency: NIDCR NIH HHS, United States
    Id: U01 DE020054
  • Agency: NIDCR NIH HHS, United States
    Id: 1R01DE01963
  • Agency: NHGRI NIH HHS, United States
    Id: R01HG003988
  • Agency: NHGRI NIH HHS, United States
    Id: U54 HG006997
  • Agency: NHGRI NIH HHS, United States
    Id: R01 HG003991

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BayGenomics ES cell line RRO017 (organism)

RRID:MMRRC_003895-UCD

Mus musculus with name BayGenomics ES cell line RRO017 from MMRRC.

View all literature mentions

BayGenomics ES cell line RRO007 (organism)

RRID:MMRRC_003888-UCD

Mus musculus with name BayGenomics ES cell line RRO007 from MMRRC.

View all literature mentions

BayGenomics ES cell line RRO016 (organism)

RRID:MMRRC_003894-UCD

Mus musculus with name BayGenomics ES cell line RRO016 from MMRRC.

View all literature mentions